Neutrophil Elastase Inhibitors (Pulmagen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNeutrophil Elastase Inhibitors (Pulmagen)
Drug Alias NameNeutrophil Elastase Inhibitors (Argenta)Neutrophil Elastase Inhibitors (Argenta)ADC-7828
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArgenta Discovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmagen TherapeuticsArgenta Discovery
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A